SYF
65
-6
BIIB
37
7
CAG
46
10
IR
72
-5
TGT
50
-2
NKE
46
12
WAT
54
2
SBUX
41
-3
FE
55
5
DAL
62
-4
ADI
59
-2
UNP
40
-2
NI
65
2
KMI
59
2
T
56
2
NAVI
55
-2
ITW
62
-2
PG
51
3
MLM
53
-5
GPC
37
-14
SYF
65
-6
BIIB
37
7
CAG
46
10
IR
72
-5
TGT
50
-2
NKE
46
12
WAT
54
2
SBUX
41
-3
FE
55
5
DAL
62
-4
ADI
59
-2
UNP
40
-2
NI
65
2
KMI
59
2
T
56
2
NAVI
55
-2
ITW
62
-2
PG
51
3
MLM
53
-5
GPC
37
-14
Financhill
Back

Virtus Reaves Utilities ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
66

UTES
Virtus Reaves Utilities ETF

Last Price:
62.55
Seasonality Move:
0.49%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
66
Virtus Reaves Utilities ETF (UTES) is a Buy

Is Virtus Reaves Utilities ETF a Buy, Sell or Hold?

  • The current Virtus Reaves Utilities ETF [UTES] share price is $62.65. The Score for UTES is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • UTES is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

UTES Stock Price Chart

What is Virtus Reaves Utilities ETF's stock price today?

  • The Virtus Reaves Utilities ETF share price today is $62.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTES is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

UTES Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.52 Buy
Relative Strength Index (14 RSI): 81.64 Buy
Chaikin Money Flow: 47822 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (55.53 - 59.13) Buy
Bollinger Bands (100): (51.98 - 56.48) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

UTES Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 59.53 Buy
20-day SMA: 57.75 Buy
50-day SMA: 55.31 Buy
200-day SMA: 49.88 Buy
8-day EMA: 59.74 Buy
20-day EMA: 58.06 Buy
50-day EMA: 56.03 Buy
200-day EMA: 51.27 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Virtus Reaves Utilities ETF Earnings Growth & UTES Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Virtus Reaves Utilities ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):